BC
GSK icon

Barnett & Company’s GSK GSK Stock Holding History

Barnett & Company’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-60
Closed -$3K – 332
2018
Q1 		$3K Hold
60
– – ﹤0.01% 294
2017
Q4 		$3K Hold
60
– – ﹤0.01% 303
2017
Q3 		$3K Hold
60
– – ﹤0.01% 310
2017
Q2 		$3K Hold
60
– – ﹤0.01% 340
2017
Q1 		$3K Hold
60
– – ﹤0.01% 322
2016
Q4 		$3K Hold
60
– – ﹤0.01% 357
2016
Q3 		$3K Hold
60
– – ﹤0.01% 375
2016
Q2 		$3K Hold
60
– – ﹤0.01% 358
2016
Q1 		$3K Buy
+60
New +$2.99K ﹤0.01% 376

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Barnett & Company's GSK Position: Q2 2018 in Review

Barnett & Company sold out of GSK (GSK) in Q2 2018, closing a stake of 60 shares — an estimated $3K sold.

Barnett & Company first reported a position in GSK in Q1 2016 and held it in 9 quarters. The position peaked at $3K in Q1 2018. 787 funds tracked by Wall St. Rank hold GSK as of Q2 2018.

  • Barnett & Company reported no remaining GSK position as of Q2 2018 after selling out during the quarter.
  • Barnett & Company sold 60 GSK shares in Q2 2018, an estimated $3K.
  • Barnett & Company first reported a position in GSK in Q1 2016 and held it in 9 quarters.
  • Barnett & Company's GSK position peaked at $3K in Q1 2018.
  • 787 funds tracked by Wall St. Rank held GSK as of Q2 2018.

Based on Barnett & Company's 13F filing for Q2 2018, filed 3 Aug 2018.